Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.67 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.56 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.53 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.51 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.51 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3643202 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL12349998 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL17203936 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL9652090 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL12350003 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL342410 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL3994160 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL15649884 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL15649498 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL11216778 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170258711-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | NOVO NORDISK AS (DK) | 2017-09-14 | — | — | US | claimed |
| CN-104884078-B | For the fatty-acylation D amino acid of oral peptide delivery | 诺和诺德股份有限公司 | 2017-06-20 | — | — | CN | claimed |
| WO-2015162195-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2015-10-29 | — | — | WO | claimed |
| US-20150265710-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | NOVO NORDISK A/S (DK) | 2015-09-24 | — | — | US | claimed |
| CN-104884078-A | Fatty acid acylated D-amino acids for oral peptide delivery | NOVO NORDISK AS | 2015-09-02 | — | — | CN | claimed |
| EP-2908846-A1 | FATTY ACID ACYLATED D-AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | Novo Nordisk A/S (DK) | 2015-08-26 | — | — | EP | claimed |
| WO-2014060447-A1 | FATTY ACID ACYLATED D-AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2014-04-24 | — | — | WO | claimed |
| US-20170258711-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | NOVO NORDISK AS (DK) | 2017-09-14 | — | — | US | disclosed |
| CN-104884078-B | For the fatty-acylation D amino acid of oral peptide delivery | 诺和诺德股份有限公司 | 2017-06-20 | — | — | CN | disclosed |
| WO-2015162195-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2015-10-29 | — | — | WO | disclosed |
| US-20150265710-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | NOVO NORDISK A/S (DK) | 2015-09-24 | — | — | US | disclosed |
| CN-104884078-A | Fatty acid acylated D-amino acids for oral peptide delivery | NOVO NORDISK AS | 2015-09-02 | — | — | CN | disclosed |
| EP-2908846-A1 | FATTY ACID ACYLATED D-AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | Novo Nordisk A/S (DK) | 2015-08-26 | — | — | EP | disclosed |
| US-20130079259-A1 | OIL RELEASE WITH POLYETHYLENE OXIDE SEGMENT-CONTAINING N-LAUROYL AMINO ACID-BASED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-28 | — | — | US | disclosed |
| US-20120292022-A1 | COMPOSITION FOR IMPROVING OIL RECOVERY INCLUDING N-LAUROYL AMINO ACID-BASED COMPOUNDS AND MICROBES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120295823-A1 | OIL RELEASE WITH N-LAUROYL AMINO ACID-BASED COMPOUNDS | E.I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120295823-A1 | OIL RELEASE WITH N-LAUROYL AMINO ACID-BASED COMPOUNDS | E.I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | US | disclosed |
| WO-2012071293-A2 | COMPOSITION FOR IMPROVING OIL RECOVERY INCLUDING N-LAUROYL AMINO ACID-BASED COMPOUNDS AND MICROBES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-31 | — | — | WO | disclosed |
| WO-2012071291-A2 | OIL RELEASE WITH N-LAUROYL AMINO ACID-BASED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-31 | — | — | WO | disclosed |
| US-3950277-A | LIPASE ENZYME AND ACTIVATORS, ALKYLNAPHTHALENE SULFONATE | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150265710-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | SLC27A1, SLC27A2, FABP2 | FAAH 83/4885MEN1 4066/4885MAPK1 4004/4885 |
| US-20170258711-A1 | Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery | SLC27A1, SLC27A2, FABP2 | FAAH 83/4885MEN1 4066/4885MAPK1 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.